Table 2.
Information about neonatal opioid withdrawal syndrome symptoms and treatment.
| Subject number | Postnatal opioid treatment for NOWS | Days of postnatal opioid exposure | Secondary medications for NOWS | Highest Finnegan score | Average Finnegan score on day of life 3 |
|---|---|---|---|---|---|
| 1 | methadone | 9 | 16 | 8 | |
| 2 | buprenorphine | 6 | 13 | 7.6 | |
| 3 | 17 | 7.9 | |||
| 4 | methadone | 10 | 12 | 8 | |
| 5 | buprenorphine | 10 | phenobarbital | 15 | 9.8 |
| 6 | 12 | 9.3 | |||
| 7 | 4 | 3 | |||
| 8 | 8 | 1.6 | |||
| 9 | 13 | 7.4 | |||
| 10 | buprenorphine | 14 | 16 | 7.6 | |
| 11 | 6 | 3 | |||
| 12 | 13 | 2.5 | |||
| 13 | buprenorphine | 6 | clonidine | 17 | 5.3 |
| 14 | 10 | 5.3 | |||
| 15 | 2 | 0.25 | |||
| 16 | 2 | 0.25 | |||
| 17 | 7 | 1.9 | |||
| 18 | 10 | 6.4 | |||
| 19 | 13 | 8.5 |